Skip to main content
. 2021 Nov 4;34(4):566–575. doi: 10.1093/icvts/ivab291

Figure 1:

Figure 1:

(A–D) PFS and OS of patients with Stage IIIA NSCLC treated with CRT or TT. CRT: chemoradiotherapy; OS: overall survival; PFS: progression-free survival; TT: trimodality treatment.